FindTrial
Sign In

A clinical trial to evaluate the efficacy and safety precisely unveiled the comparative effectiveness of Sadangpaniya-phanta,Vayasathapana-kasya ghana tablet and Viyoshadi churna tablet in the treatment of COVID-19

A randomized, open label,controlled,pragmatic trial to evaluate the efficacy and safety of Sadangpaniya phanta,Vayasathapana-kasaya ghana tablet and Viyoshadi churna tablet in the treatment of COVID-19

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/08/035468
Enrollment
70
Registered
2021-08-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B338- Other specified viral diseases Health Condition 2: B338- Other specified viral diseases

Interventions

Intervention1: Sadangpaniya kwath ,Viyosadi churn tablet ,Vyasthapan kasay ghana tablet: Sadangpaniya kwath ,Viyosadi churn tablet ,Vyasthapan kasay ghana tablet-INTERVENTION Conventional allopathic

Sponsors

Dr Rajesh Adhana
Lead Sponsor
Dr Asutosh Chohan
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Patient with mild symptoms of covid-19( Rapid test and RT-PCR) positive case will be enrolled.

Exclusion criteria

Exclusion criteria: Patient with moderate and sever Covid-19 infection having Pneumonia, Pregnant female patient with covid-19 infection will be excluded.

Design outcomes

Primary

MeasureTime frame
Clinical recovery will be defined as sustained alleviation of illness based on symptom scores fever,cough,diarrhea,myalgia,dyspnea,all being absent.Timepoint: 10 days—

Secondary

MeasureTime frame
Symptomatic recovery as cough fever with on SpO2 decline greater than3% and respiratory rate more than 30 per minute and no feeling of weakness and no insomniaTimepoint: 28 days—

Countries

India

Contacts

Public ContactDr Rajesh Adhana

Gurukul Kangari parisar

vaidadhanarajesh@gmail.com9412956506

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026